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Abstract
This paper describes the psychometric properties of the PROMIS Pain Interference (PROMIS-PI)
bank. An initial candidate item pool (n=644) was developed and evaluated based on review of
existing instruments, interviews with patients, and consultation with pain experts. From this pool,
a candidate item bank of 56 items was selected and responses to the items were collected from
large community and clinical samples. A total of 14,848 participants responded to all or a subset
of candidate items. The responses were calibrated using an item response theory (IRT) model. A
final 41-item bank was evaluated with respect to IRT assumptions, model fit, differential item
function (DIF), precision, and construct and concurrent validity. Items of the revised bank had
good fit to the IRT model (CFI and NNFI/TLI ranged from 0.974 to 0.997), and the data were
strongly unidimensional (e.g., ratio of first and second eigenvalue = 35). Nine items exhibited
statistically significant DIF. However, adjusting for DIF had little practical impact on score
estimates and the items were retained without modifying scoring. Scores provided substantial
information across levels of pain; for scores in the T-score range 50-80, the reliability was
equivalent to 0.96 to 0.99. Patterns of correlations with other health outcomes supported the
construct validity of the item bank. The scores discriminated among persons with different
numbers of chronic conditions, disabling conditions, levels of self-reported health, and pain
intensity (p< 0.0001). The results indicated that the PROMIS-PI items constitute a
psychometrically sound bank. Computerized adaptive testing and short forms are available.
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Introduction
Pain interference (also known as “pain impact”) refers to the degree to which pain limits or
interferes with individuals' physical, mental and social activities. This domain is increasingly
recognized as important for both understanding patients' experiences and as a key outcome
in pain clinical trials [22]. A number of measures of pain interference have been developed
including a 9-item scale from the West Haven-Yale Multidimensional Pain Inventory
(WHYMPI) [31], a 7-item scale from the Brief Pain Inventory [14,19], a 6-item Pain Impact
Questionnaire (PIQ-6) [2], a 3-item scale from the Chronic Pain Grade [57], and the 7-item
Pain Disability Index [42]. Available evidence supports the validity and reliability of these
scales as measures of pain interference, although each has strengths and weaknesses
[15,31,42,57] (see also reviews [22,36]). One weakness of existing instruments is that they
are static measures; they require respondents to complete all items, even items that provide
no additional information about a person's level of pain interference. Although there are
exceptions [2,34], most prior work in the development of pain interference instruments has
been limited to Classical Test Theory approaches (CTT). CTT provides the theoretical and
mathematical bases for traditional estimates of reliability and validity [1], however it has
limited usefulness in evaluating the functioning of individual response options and how
precisely items measure across the continuum of pain interference, from little to severe pain
interference [26,27].
An alternative approach to the measurement of patient-reported outcomes (PROs) is to
develop banks of items that measure the outcome of interest and calibrate responses to these
items using an item response theory (IRT) model [17,49,59]. IRT-calibrated instruments
provide options such as: (1) computer adaptive testing (CAT), which provides precise
measurement using few items; (2) the ability to compute scores that are directly comparable
even when respondents take different items, facilitating comparisons across time and
between different samples; and (3) development of population-specific short forms
containing items of most relevance to a specific population. A priori expectations for what
constitutes a psychometrically sound item bank for measuring pain interference include
providing reliable scores (Cronbach's alpha > 0.85) with minimal respondent burden, and
having a minimal number of items with differential item functioning (DIF). In addition, the
validity of the scores should be evidenced by correlations >0.80 with scores on established
instruments that measure pain interference.
The National Institutes of Health's (NIH) Patient-Reported Outcomes Measurement
Information System (PROMIS) initiative [10,11,20,43,44,50] targeted four pain
subdomains: interference, quality, behaviors and intensity. The purpose of this paper is to
describe the development of the PROMIS item bank for measuring pain interference. The
specific aims of this project were to:
1. Administer candidate items to large community and clinical samples
2. Conduct psychometric analyses, including:
a. Checking that assumptions for IRT models are met
b. Fitting a graded response model to the data, examining item fit, removing
items that do not fit the model and calibrating final items;
Amtmann et al. Page 2

















Development of a Candidate Item Bank
Items that become part of an IRT-calibrated item bank must survive intense psychometric
scrutiny; therefore, it is important to test more items than are needed in a final bank. It also
is critical that the items adequately sample the content of the domain being measured and,
collectively, target all levels of the domain that might be observed in a study population.
Development of the candidate PROMIS item bank began with the collection and
classification of a “library” of pain interference items (n=644). These items were identified
based on an extensive literature review and feedback from persons experiencing pain.
Details of the general item development process used by PROMIS have been published
elsewhere [20]. Briefly, all pain interference items were reviewed and revised by members
of an expert panel of researchers who had expertise in pain assessment, language translation,
literacy or psychometrics. After initial revisions were made, persons who had pain
participated in in-person interviews to evaluate item clarity, content, and appropriateness.
Based on the results of these interviews, item revisions were made. A subset of 56 items was
identified to constitute a candidate item bank for measuring pain interference-- the
PROMIS-PI item bank. The temporal context for all items was seven days (e.g., “In the past
seven days, how much did pain interfere with your enjoyment of life?”). Response options
were initially limited to four sets: (1) not at all, a little bit, somewhat, quite a bit, very much;
(2) never, rarely, sometimes, often, always; (3) never, once a week or less, once every few
days, once a day, every few hours; and (4) never, 1 night, 2-3 nights, 4-5 nights, 6-7 nights.
These response categories were examined through in-person interviews to ensure that they
were meaningful to and easily understood by individuals living with pain. Participants were
asked whether each item had just enough, too few, or too many response options, and
whether the response options made sense.
Collection of Item Responses from Clinical and Community Samples
Two types of sources were used to recruit subjects for the current analyses: (1) the PROMIS
Wave I data collection and (2) two additional community samples of individuals who were
likely to experience chronic pain. The PROMIS Wave 1 data collection served the diverse
psychometric needs of developing 14 different item banks. To meet these needs a large and
complex sampling design was developed. Detailed description of the PROMIS sampling
design is outside the scope of this paper, however, a diagram and description of the Wave I
data collection is presented in detail on the PROMIS website (www.nihpromis.org) under
the subheading “Wave 1 Testing”.
PROMIS Wave I
PROMIS Metric: With IRT models, scores representing the domain of interest are
calibrated in logits that generally range from approximately -4 to +4 [26]. Because it is not
intuitive to report health outcomes in negative numbers, researchers typically do a linear
transformation of IRT-calibrated scores so that all scores are positive. By consensus,
PROMIS decided that the metric for all PROMIS measures would be the T-score metric [35]
in which scores have a mean of 50 and a standard deviation (SD) of 10. The advantage of
this scoring approach is that a person's score on any PROMIS measure communicates that
person's level of the domain relative to the general population. For example, a person who
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has a PROMIS-PI score of 70 has a pain interference level approximately two SDs above the
estimated national average.
Wave I Measures: In a large-scale data collection (Wave 1 testing), responses were
collected to items of 14 PROMIS candidate item banks including the Pain Interference bank.
The process described above in which a “library” of 644 pain interference items was
reduced to a candidate item bank of 56 was paralleled for all 14 PROMIS domains.
Responses to a total of 784 PROMIS items representing the 14 domains were tested in Wave
1. For validity testing, items from “legacy measures” also were administered. A legacy
measure is defined as one that has demonstrated reliability and validity and is widely
accepted in the relevant application. The legacy measures for testing the validity of the
PROMIS-Pain Interference (PI) bank included the 7-item pain interference subscale of the
Brief Pain Inventory (BPI) [13] and the 2-item Bodily Pain Subscale of the Medical
Outcomes Short Form-36, version 2-acute [60,61].
In addition to PROMIS candidate items and legacy items, two global health items were
administered. Respondents were asked, “In general, would you say your health is excellent/
very good/good/fair/poor,” and, “How would you rate your pain on average?” (“0=no pain”
through “10=worst imaginable pain”).
Wave I Sample: A total of 21,133 total persons participated in Wave 1 testing. Of these,
1,532 were recruited from PROMIS research sites. The other 19,601 were recruited through
YouGovPolimetrix (www.polimetrix.com, also see www.pollingpoint.com), a polling firm
based in Palo Alto, California. Data obtained through YouGovPolimetrix and PROMIS
research sites were collected using websites on secure servers. The primary research sites
and the YouGovPolimetrix sample included both community and clinical samples. The
clinical samples included persons with heart disease (n = 1,156), cancer (n = 1,754),
rheumatoid arthritis (n = 557), osteoarthritis (n = 918), psychiatric illness (n = 1,193), COPD
(n = 1,214), spinal cord injury (n = 531), and other conditions (n = 560).
The large number of items made it impractical to administer all items to all persons. To
obtain sufficient responses to the items of the 14 candidate PROMIS item banks, data
collection was divided into two arms. In a “full bank” testing arm, 7,005 persons were
administered all items of two of the fourteen, 56-item, candidate PROMIS item banks. For
example, one group of participants responded to all 56 items measuring pain interference
and all 56 items measuring pain quality. Another group responded to all 56 items of the
PROMIS anger item bank and all 56 items of the depression item bank. The second arm of
Wave I data collection was a “block testing” arm. For this data collection arm, the 56 items
of each item bank were divided into eight, 7-item blocks (8 blocks × 7 items = 56 items of
the item bank).
Respondents were included in the Wave I analysis if they responded to 50% or more of the
items, did not have repetitive strings of ten or more identical responses (except for response
strings of “no pain”), and their response time was greater than one second per item. A total
of 14,848 persons met inclusion criteria and responded either to the full, 56-item PROMIS-
PI bank (N=845) or to one of the eight, 7-item Pain Interference blocks (N=14,003).
Supplementary Data Collection—In spite of the large data sample in the Wave I data
collection, there were relatively few persons who reported severe levels of pain (that is, pain
intensity scores of 7 or greater on a 0-10 scale). For 47 of the 56 candidate PROMIS-PI
items, more than half of respondents indicated no pain interference (range across items =
27.7% to 79.3% reporting no pain interference). At the other end of the pain interference
continuum, for 49 of the 56 items, the highest category (indicating highest level of pain
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interference) was endorsed by 5% or less of the sample (range across items = 0.6% to
25.7%). In order to obtain accurate item parameter estimates for items that target higher
levels of pain intensity, we added data collected from participants with cancer as part of a
project conducted earlier by the PROMIS Statistical Coordinating Center, and we initiated
an online survey through the American Chronic Pain Association (ACPA). Before starting
the ACPA data collection, nine items were removed from the candidate PROMIS-PI bank
based on initial psychometric analyses following Wave I data collection and secondary
review by content experts. Of the nine items removed, five were removed because of poor
fit, three items were removed because they did not specifically mention pain, and one item
was removed because of poor correlation with other items in the bank. This left a revised
candidate item bank with 47 items.
Cancer Sample (n=532): 1,754 patients with cancer were included in the PROMIS Wave I
sample. Because of the high incidence of pain in persons with cancer [8], we anticipated that
including additional patients with cancer likely would increase endorsement of response
categories indicating higher pain interference. To obtain these additional participants, we
used data that the PROMIS Statistical Coordinating Center had collected from a
convenience sample of 532 persons with cancer. This study included persons with any
cancer diagnosis at any stage, severity, or treatment status (active or follow-up). Data were
collected from two cancer clinics (NorthShore University HealthSystem and John H.
Stroger, Jr. Hospital of Cook County), and from cancer support societies in the Chicago area
and across the country. Participants were administered 39 of the 47 items in the revised,
candidate Pain Interference bank. This 39-item subset of the 56 candidate PROMIS-PI items
was selected based on the needs of the prior study. The BPI Interference scale, the 0-10
numerical rating scale of pain intensity items (present, least, worst, and average pain), and
SF-36 Bodily Pain Subscale were not administered in this sample.
American Chronic Pain Association (ACPA) Sample (n=523): To increase the clinical
sample size further, participants with chronic pain were recruited through the ACPA. An
invitation to complete the PROMIS pain survey was posted on the ACPA website. To be
eligible, participants had to be 21 years of age or older and have at least one chronic pain
condition for at least 3 months prior to participating in the survey. Those who met eligibility
criteria were asked to provide informed consent. Those who did so were immediately
administered the survey that consisted of the 47-item PROMIS Pain Interference candidate
bank as well as clinical items and demographic questions. Respondents were not paid for
their participation, reducing the likelihood that individuals without chronic pain would fill
out the survey in order to receive a stipend. PROMIS assessment center was used for the
data collection and data were screened for quality using the same procedures used for all
PROMIS data (e.g., time it took to complete each question, strings of the same responses).
To limit response burden, the BPI Interference Subscale, numerical rating scale, and SF-36
Bodily Pain Subscale were not administered in this sample. The invitation to participate in
the survey was posted on the ACPA website from August 2007 to February 2008.
Responses to Items Related to Emotional Aspects of Pain: Different types of chronic pain
may be associated with different responses to items related to emotional aspects of pain. To
ensure that the Wave I, cancer, and chronic pain samples did not differ significantly in their
emotional responses to pain, we calculated the mean item responses (range of 1-5) to the 7
items in the bank that referenced emotional components of pain (e.g., “How often did pain
make you feel depressed?”). We compared these mean item scores to mean scores on the
non-emotional items for participants in each of our 3 samples—those with chronic pain,
those with cancer, and those from the PROMIS Wave I sample. Table 1 reports the results.
We found that patterns of responses of those with cancer were very similar to those in the
Wave I sample, both with respect to mean item scores and mean differences in item scores.
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Compared to those with cancer and those in the Wave 1 sample, those with chronic pain
endorsed higher response categories on average for both emotional and non-emotional pain
impact items. Differences between emotional and non-emotional items were also higher in
this group than for the other two samples. However, the differences in all groups were
relatively small—less than one quarter of a category on average for the chronic pain sample
(on a scale from 1 to 5).
Reduction of Candidate Item Pool to 41-Item Bank—The combined data from the
Wave I sample and from the auxiliary samples (cancer and chronic pain patients) were used
to conduct analyses of the 47-item candidate item pool. Based on evaluations of
dimensionality, fit to the Graded Response Model (GRM) [51], and additional review by
content experts, the number of items was reduced to 41 (see Appendix A for a list of the
final 41 item bank of Pain Interference items). To evaluate the content representation of the
final bank, we compared the content subdomains represented in the original 56 items to
those represented in the final 41-item bank. Eleven hypothesized pain interference
subdomains were represented in the original item bank; items targeting ten of these were
retained in the final bank. Because of concerns about multidimensionality, poor model fit,
and/or discriminant validity, the single item related to sex was dropped as were 4 of 5 sleep
items, 3 of 4 travel items, and 3 of 4 walking items. The majority of items representing all
other pain interference subdomains were retained. In the 41-item bank, 8 items target
activities of daily living and work; 4 cognition; 7 emotional function; 4 fun, recreation, and
leisure; 1 sleep; 10 social function; and 7 sitting, walking and standing. All analytic results
reported below are based on this 41-item bank. Item elimination also reduced the original
four response sets to three response sets in the final 41-item bank.
Analyses
IRT Assumptions
IRT is a probability model and estimation of scores is achieved without the requirement that
every person respond to the same items [23]. Unidimensional IRT models (as do CTT
models) make the assumption that a single latent construct drives the variance in scores.
Health outcomes are conceptually complex and responses to items of health outcome
measures rarely, if ever, meet a strictly interpreted unidimensionality assumption [18,45,46].
The pertinent question is whether the presence of secondary dimensions disturbs parameter
estimates when responses are calibrated using unidimensional IRT models [47,48]. The
typical approach to evaluating this question is to assess the strength of a common dimension.
The published PROMIS analysis plan [44] suggested the use of confirmatory factor analysis
(CFA) in which a unidimensional model is applied and fit statistic values are compared to
prior published criteria by Hu and Bentler [3,28,29], McDonald [37], and others [6,33,62].
These criteria included: Comparative Fit Index (CFI) >0.95, Root Mean Square Error of
Approximation (RMSEA) <0.06, Tucker Lewis Index or Non-normed Fit Index (NNFI)
>0.95, and Standardized Root Mean Square Residual (SRMR) <0.08 [44]. Recognizing the
difficulty of attaining CFA standards in the context of item banking (e.g., because of large
number of items) alternative standards based on exploratory factor analysis (EFA) results
were suggested [44]. As stated in the PROMIS analysis plan, support for unidimensionality
is considered sufficient when the first factor accounts for at least 20% of the variability, the
ratio of first and second eigenvalues is greater than 4, and the results of scree test,
correlations among factors, and factor loadings support the hypothesized structural patterns
[44]. In addition, we conducted a parallel analysis of the raw PROMIS data based on
principal axis/common factor analysis and on the distribution of the raw data set [39]. The
magnitudes of eigenvalues expected by chance alone were computed and compared to
observed eigenvalues to estimate the maximum number of underlying dimensions. If the
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results of the CFA and EFA analyses produced evidence for secondary dimensions, bi-factor
model analyses were planned to assess the level of disturbance in item parameter estimates
attributable to multidimensionality.
A second assumption of IRT models is local independence. Local independence holds if,
after accounting for the dominant factor, there is no significant association among item
responses [52,63]. Local dependency (LD) can adversely impact IRT parameter estimates.
To evaluate LD, we examined the residual correlation matrix produced by the single factor
CFA. Residual correlations whose absolute values are greater than 0.10 [44] are of some
concern, but of particular concern are absolute residual correlations greater than 0.20 [18].
IRT Calibration and Fit
We modeled responses to the 41 items of the candidate PROMIS-PI items using Samejima's
two parameter polytomous graded response model (GRM) [51] with Multilog, Version 7.03
[55]. GRM is an IRT model suitable for ordered polytomous responses. One of the
advantages of IRT, as compared to CTT, is that IRT is based on a mathematical model that
allows comparison of the patterns of actual responses to those predicted by the model. How
closely the actual data correspond to the predictions of the model can be quantified and
summarized by goodness-of-fit statistics.
Fit to the GRM was calibrated using the computer macro, IRTFIT [5]. We report values of
S-X2 (a Pearson X2 statistic) and S-G2 (a likelihood ratio G2 statistic) [40,41]. These
statistics compare expected and observed frequencies of item category responses for various
levels of scores and quantify the differences between expected and observed responses.
Reliability Analysis
In CTT, single reliability estimates are calculated for the entire scale despite the fact that the
scale is likely to provide more precise measurement at different levels of the domain being
measured. In IRT the concept of reliability is conceptualized as “information” and extended
to take into account the fact that measurement precision can differ across levels of the
domain being measured. The relationship between standard error (SE) and information is
defined by the formula, , where SE is the standard error of the posterior
distribution, I is information, and θ is estimated domain level (from no or mild pain
interference to high levels of pain interference). As the formula indicates, increased scale
information is associated with smaller SE's and, therefore, greater precision. To determine
the effects of domain level on precision, we plotted information for the 41-item PROMIS-PI
item bank and compared the results to the distribution of Pain Interference scores in the
calibration samples.
Validity Analyses
The construct validity of the PROMIS-PI was evaluated by comparing PROMIS-PI scores to
scores from measures of similar domains [9] including the BPI Interference Subscale [13],
the SF-36 (version 2-acute, 7 day recall) Bodily Pain Subscale (SF-36 BP) [60,61], and a
0-10 Numerical Rating of Pain Intensity [30]. Also evaluated was the association between
PROMIS-PI scores and scores on PROMIS measures of theoretically different domains (i.e.,
anxiety, depression, fatigue, and physical function).
To evaluate concurrent validity, we assessed how well PROMIS-PI scores distinguished
between and among “known groups.” That is, we evaluated whether PROMIS-PI scores
distinguished among subgroups that, theoretically, should differ in mean scores. Analyses of
Variance (ANOVAs) were conducted to compare mean scores of those who reported
different levels of “average health” (excellent, very good, good, fair, poor). ANOVAs also
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were conducted to compare PROMIS-PI scores based on numbers of chronic and disabling
conditions reported and based on levels of pain intensity.
Differential Item Functioning
Analysis of differential item functioning (DIF) examines the relationships among item
responses, levels of the domain being measured, and subgroup membership. For any given
level of domain, the probabilities of endorsing specified item responses should be
independent of subgroup membership [25]. In the context of pain interference measurement,
persons of different ages, education-levels, race/ethnicities, and genders who have equal
levels of pain interference should be equally likely to endorse a particular category of a
specified PROMIS-PI item. For example, men and women who are equal in their levels of
pain interference should be equally likely to respond, “somewhat” to the item, “How much
did pain interfere with work around the home?” When items function similarly across
demographic groups (do not exhibit DIF), direct comparison of group scores are justified,
even when persons respond to different items from the item bank. DIF can be consistent
across the range of the domain being measured (uniform DIF), or its impact can vary for
persons with different levels of the domain being measured (non-uniform DIF). For the
current study, DIF analyses were conducted with freeware developed for testing DIF using
ordinal logistic regression (OLR) [12,64]. Likelihood-ratio χ2 statistics compared OLR
models with and without subgroup membership as a predictor. DIF was evaluated with
regard to age (under 65 versus 65 and over), education-level (high school or less versus
some college or higher), and gender (male versus female).
Results
Sample Characteristics
Table 2 provides demographic details for the PROMIS Wave I data and for the auxiliary
samples. Across all samples, the majority of respondents were white (83.4%) and female
(54.0%). Respondents were well educated; 44.9% had at least a college degree and 79.7%
had at least some college or technical school. The average age of the combined sample was
54 years.
IRT Assumptions
Dimensionality assessment was evaluated using CFA fit statistics, EFA results, and parallel
analysis. The chi-square statistic is sensitive to sample size [7] and as expected it was
statistically significant (χ2 (68, N = 15,903) = 2624, p < .001). The CFI and NNFI/TLI
values were very high at 0.974 and 0.997, respectively, well beyond published fit criteria of
>0. 95. Likewise the SRMR value of 0.033 was well below the published criterion of < 0.08.
However, the RMSEA was 0.175, which is well beyond the published criterion of < 0.06.
This finding is not surprising given our previous work that found that RMSEA values tend
to be elevated when there are larger numbers of items, and this statistic may not be
appropriate for judging dimensionality of a large item bank [16].
EFA results supported sufficient unidimensionality. The first factor accounted for 86% of
the variance; and the second factor accounted for 2% of the variance. The first eigenvalue
was 35.3 and the second was 1.0. Moreover, the first and second factor identified by the
EFA were highly correlated (r= 0.76). These results concur with those of the parallel
analysis; only the first factor had an eigenvalue greater than that expected by chance alone.
We examined the items that loaded higher on the second factor than on the first factor to
evaluate whether a clinically interesting second factor could be identified and potentially
scored. The items with higher loadings on the second factor related to working, doing
household chores, avoidance of social activities because of pain, and difficulties with sitting
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for a period of time and thus did not provide evidence for a conceptually distinct secondary
dimension. Because the combined results of these analyses strongly suggested a single
dominant factor, we did not conduct follow-up bi-factor model analysis.
Examination of the residual correlations indicated very little local dependence. The average
absolute value of the residual correlations was 0.03. A total of 8 (<1 %) were greater than
0.10, and none were greater than 0.13. The three possible pairs of items PI50, PI51, and
PI55 all had residual correlations of 0.13. Each of these items asks about pain interference
on sitting. Based on these results we judged the level of local dependency to be minor and
not to pose a substantial threat to the accuracy of IRT parameter estimation.
IRT Calibration and Fit
As described above, the metric of the calibration was anchored to a community sample and
weighted to reflect the 2000 United States Census [35]. Scores are reported on a T-score
metric and ranged from 40.1 to 80.4, roughly one SD below to 3 SD above the population
mean. Appendix A presents the content, response sets, and item parameters of the PROMIS-
PI. Pain interference items were scored so that higher scores indicated greater pain
interference. Figure 1 displays the distribution of scores by sample. Only scores for persons
who responded to at least seven items (the number of items administered in the Wave I
block design) are reported here. As the plots show, and as mentioned above, a large portion
of the PROMIS Wave I respondents reported experiencing no pain interference; 33%
answered “not at all” or “never” to every item. Of the respondents from the cancer sample
obtained from the PROMIS Statistical Coordinating Center, 21% reported no pain
interference. As expected, all of the ACPA respondents reported at least some pain
interference. Based on an alpha value of 0.01, no items were found to misfit the GRM.
Probability values for S-X2 statistics ranged from 0.102 to 0.998 (mean = 0.761).
Probabilities for S-G2 statistics ranged from 0.053 to 0.998 (mean = 0.731).
Reliability Analyses
The Cronbach alpha estimate for the PROMIS-PI bank was 0.99. Figure 2 is a plot of total
information by Pain Interference T-scores for the combined samples (PROMIS Wave I,
ACPA, and Cancer samples). Reference lines indicate levels of information approximately
equivalent to reliability estimates of 0.90 and 0.95. As the plot demonstrates, the bank
provides substantial information across levels of domain observed in the combined sample
(T-score range 40.1-80.4). In fact, for the range of the mean (score of 50) to three standard
deviations above the mean (score of 80), the bank provides information equivalent to
reliability of 0.96 to 0.99.
Validity Analyses
Table 3 reports correlation coefficients that estimate the associations between PROMIS-PI
scores and scores on other PROMIS measures and other pain-related measures. Pearson r
was used to correlate PROMIS scores (thetas) because they met assumptions of equal
distances between the units of the scale. A non-parametric indicator (Spearman Rho) was
used to estimate associations between PROMIS pain interference scores and ordinal-level
scores, i.e., the pain intensity score, the SF-36 BP score, and the BPI interference score. The
PROMIS-Physical Function items and the SF-36 BP Subscale are scored so that higher
scores indicate greater function and less pain, respectively. The pattern of associations is
consistent with expectations and supports the construct validity of the PROMIS-PI item
bank. As expected, the strongest correlations were with measures of pain-related domains—
BPI Interference Subscale (rho = 0.90), SF-36 Bodily Pain Subscale (rho = - 0.84), and 0-10
Numerical Rating of Pain Intensity (rho = 0.48). Also as expected, the associations were
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weakest with PROMIS measures of mental health domains (r = 0.33 with PROMIS-
Depression, r = 0.35 with PROMIS-Anxiety).
Table 4 reports the results of ANOVAs evaluating the PROMIS-PI scores in discriminating
known groups. As indicated in the table, the PROMIS-PI score means increased stepwise
with increases in number of chronic conditions, number of disabling conditions, and
decreases in reported general health. These comparisons were all statistically significant
with probabilities < 0.0001.
Differential Item Function Detection
None of the items had statistically significant education DIF, nor was any statistically
significant non-uniform DIF found among the 41 PROMIS-PI items. However, nine items
had statistically significant uniform DIF. One item had gender-related DIF—Item P3, “How
much did pain interfere with your enjoyment of life?” Eight items had statistically
significant age-related DIF—Items P1, P8, P11, P40, P42, P47, P49, and P56 (see Appendix
A). Of these, three related to the cognitive interference of pain (taking in information,
concentrating, remembering); two referred to emotional interference (emotionally tense,
irritable); and three referred to walking or standing. We evaluated the practical impact of
DIF by calibrating group-specific item parameters for all items with statistically significant
DIF and then comparing scores based on these “corrected” item parameters to those
obtained with the original parameters. Accounting for the one item with gender DIF had
negligible effects on individual scores. The differences in T-Scores (original minus DIF-free
estimates) ranged from -1.79 to 4.44 (observed T-Scores ranged from 40.1 to 80.4). Only 8
participants (0.6%) had score differences greater than ± 2.50 (± 2 times the median standard
error). The impact of age-related DIF was more substantial. Of 1,276 respondents, 37 (2.9%)
had absolute score differences greater than 2.50.
Discussion
The results of this study indicate that the PROMIS-PI items constitute a psychometrically
sound item bank for assessing the negative effects of pain on functioning in the range
experienced by the vast majority of people who have pain. This conclusion is supported by
findings concerning (1) unidimensionality, (2) item fit to the IRT model, (3) reliability of the
PROMIS-PI scores across different levels of pain interference, (4) associations between
PROMIS-PI scores and other measures, (5) and the independence of function of the large
majority of items with respect to subgroup membership.
There are several advantages of the PROMIS-PI over traditional measures of pain
interference. The item bank can be used to develop short forms for particular purposes or
samples, or the items can be administered using CAT. Scores on short forms and on CAT
are reported in the same metric and are directly comparable. Also, through the PROMIS
Assessment Center, pain interference can be measured in context with other domains (e.g.
depression, anxiety, physical function, fatigue, social health) and scores can be graphically
displayed and compared with respect to national and subgroup norms. A major strength of
the PROMIS-PI bank is that scores have inherent meaning; they communicate respondents'
levels of a domain relative to the general population. Thus, the PROMIS PI bank advances
the measurement of pain interference.
Responses to self-reported items measuring complex constructs are never strictly
unidimensional. However, the results of our analyses support the conclusion that the pain
interference domain, at least as measured by the PROMIS-PI item bank, is a homogenous
construct. These results have conceptual as well as psychometric implications.
Psychometrically, the results strongly support the use of one summary score. Conceptually,
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they suggest that pain interference is a relatively “narrow band” domain [45]. The PROMIS-
PI item responses exhibited high internal consistency and a single factor dominated despite
inclusion of items representing multiple hypothesized pain interference subdomains. The
results are consistent with EFA results from most (but not all) analyses of other measures of
pain interference [14,32] and consistent with the high internal consistency estimates
obtained for other pain interference measures [4,31,38,53,56,58,59].
The PROMIS-PI scores proved to be highly reliable in the T-score range of 50 and 80. They
were less reliable in score ranges representing no pain interference to mild pain interference
(e.g., scores that are >1 SD below the population mean) and in score ranges reflecting very
severe pain interference (e.g., scores that are >3 SD above the population mean). However,
the range of high reliability for the PROMIS-PI scores corresponds to the range reported by
most individuals in our samples (see Figure 2). For instance, among the ACPA clinical
sample, no individuals had a score lower than 40 and only 5 individuals (less than 1%) had
PROMIS-PI score over 80.
Strong support for the validity of PROMIS-PI scores was observed in the pattern of
correlations with other measures and the scores ability to discriminate among individuals
with different levels and numbers of chronic conditions, disabling conditions, and general
health. Pain intensity and pain interference scores had approximately 25% shared variance
(rho = .487), suggesting that the pain interference and pain intensity are related, but distinct
domains.
The findings concerning differential item function support the use of the PROMIS-PI items
(and the interpretation of the PROMIS-PI scores) across samples that differ in educational
level (no differences were found) and gender (difference found in only one item). DIF was
of somewhat greater concern with respect to age (8 items were found to have statistically,
age-related DIF). However, though DIF reached statistical significance, its practical impact
on scores was minor. We judged this impact to be negligible, retained all items in the bank,
and did not construct scoring tables that would account for these differences. Nevertheless,
future studies should evaluate the impact of DIF on PROMIS-PI scores obtained using CAT.
Additionally, in selecting items from the bank for short forms, we recommend giving
preference to items that exhibited no statistically significant DIF.
Study Limitations and Future Research Directions
Although the findings provide preliminary support for the validity and reliability of the
PROMIS-PI item bank, validation is an ongoing process, and no single study can provide all
the information needed to fully understand the strengths and weaknesses of a measure. Data
for the current study were obtained from large community samples that included healthy
individuals as well as individuals with a number of specific health problems. Although these
samples represent a large range of individuals, it would be useful to expand the evaluation of
the PROMIS-PI to additional subgroups, such as persons with specific pain conditions (e.g.,
headache, low back pain, post-herpetic neuralgia), individuals with other health conditions
who often have pain as a secondary complaint or symptom (e.g., patients with multiple
sclerosis, cerebral palsy, neuromuscular disease), in ethnic/racial minority samples and in
persons with lower levels of education.
In addition, although we performed a variety of analyses useful for determining the
psychometric properties of the PROMIS-PI items, additional analyses would be helpful for
interpreting the PROMIS PI scores. The interpretability of the PROMIS metric could be
extended by estimating score differences representing meaningful category intervals (e.g.,
“clinically important difference”, “clinically meaningful change”). Another important step,
and one seldom undertaken with health outcome measures, is to develop supportable
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inferences based on PROMIS-PI scores [52]. These would include, for example, associating
PROMIS-PI scores and score changes with clinical markers or “actionable” events, such as
change in medication or referral to specialists.
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Appendix A: Item Content, Responses and Parameter Estimates
Itemˆ Response Set* Item Stem b 1 b 2 b 3 b 4 a
PI1 A
How difficult was it for you to take in new
information because of pain? 0.784 1.356 1.985 2.617 3.275
PI3 A
How much did pain interfere with your
enjoyment of life? 0.059 0.798 1.3 1.794 5.316
PI5 A
How much did pain interfere with your
ability to participate in leisure activities? 0.165 0.81 1.29 1.821 5.549
PI6 A
How much did pain interfere with your
close personal relationships? 0.571 1.093 1.614 2.1 4.389
PI8 A
How much did pain interfere with your
ability to concentrate? 0.338 1.07 1.668 2.329 3.725
PI9 A
How much did pain interfere with your day
to day activities? 0.105 0.833 1.362 1.962 6.511
PI10 A
How much did pain interfere with your
enjoyment of recreational activities? 0.077 0.706 1.139 1.722 5.718
PI11 A
How often did you feel emotionally tense
because of your pain? 0.302 1 1.49 2.16 3.666
PI12 A
How much did pain interfere with the things
you usually do for fun? 0.136 0.753 1.181 1.759 5.814
PI13 A
How much did pain interfere with your
family life? 0.405 0.973 1.497 2.049 5.642
PI14 A
How much did pain interfere with doing
your tasks away from home (e.g., getting
groceries, running errands)? 0.374 0.932 1.342 1.894 5.201
PI16 B
How often did pain make you feel
depressed? 0.398 1.001 1.756 2.421 3.158
PI17 A
How much did pain interfere with your
relationships with other people? 0.517 1.134 1.703 2.45 4.787
PI18 A
How much did pain interfere with your
ability to work (include work at home)? 0.193 0.842 1.36 1.875 4.817
PI19 A
How much did pain make it difficult to fall
asleep? 0.19 0.911 1.448 2.078 2.911
PI20 A
How much did pain feel like a burden to
you? 0.062 0.717 1.166 1.706 4.435
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Itemˆ Response Set* Item Stem b 1 b 2 b 3 b 4 a
PI22 A
How much did pain interfere with work
around the home? 0.107 0.764 1.249 1.863 5.541
PI24 B How often was pain distressing to you? -0.049 0.556 1.281 2.058 3.741
PI26 B
How often did pain keep you from
socializing with others? 0.528 1.06 1.632 2.338 4.803
PI29 B
How often was your pain so severe you
could think of nothing else? 0.548 1.087 1.802 2.823 3.378
PI31 A
How much did pain interfere with your
ability to participate in social activities? 0.405 0.925 1.393 1.959 6.185
PI32 B
How often did pain make you feel
discouraged? 0.135 0.698 1.401 2.176 3.596
PI34 A
How much did pain interfere with your
household chores? 0.11 0.771 1.269 1.87 5.018
PI35 A
How much did pain interfere with your
ability to make trips from home that kept
you gone for more than 2 hours? 0.676 1.095 1.523 1.984 4.656
PI36 A
How much did pain interfere with your
enjoyment of social activities? 0.275 0.868 1.365 1.909 5.604
PI37 B How often did pain make you feel anxious? 0.349 0.987 1.715 2.471 3.032
PI38 B
How often did you avoid social activities
because it might make you hurt more? 0.483 0.895 1.458 2.166 4.761
PI39 B
How often did pain make simple tasks hard
to complete? 0.067 0.655 1.39 2.194 4.073
PI40 B
How often did pain prevent you from
walking more than 1 mile? 0.286 0.624 0.977 1.366 3.395
PI42 B
How often did pain prevent you from
standing for more than one hour? 0.325 0.7 1.084 1.523 3.155
PI46 B
How often did pain make it difficult for you
to plan social activities? 0.398 0.872 1.458 2.02 4.797
PI47 B
How often did pain prevent you from
standing for more than 30 minutes? 0.286 0.697 1.153 1.641 3.401
PI48 A
How much did pain interfere with your
ability to do household chores? 0.166 0.742 1.243 1.832 4.888
PI49 A
How much did pain interfere with your
ability to remember things? 0.901 1.452 1.999 2.546 3.075
PI50 B
How often did pain prevent you from sitting
for more than 30 minutes? 0.655 1.15 1.696 2.297 3.206
PI51 B
How often did pain prevent you from sitting
for more than 10 minutes? 0.954 1.565 2.207 2.799 2.971
PI52 B
How often was it hard to plan social
activities because you didn't know if you
would be in pain? 0.631 1.048 1.552 1.984 4.611
PI53 B
How often did pain restrict your social life
to your home? 0.446 0.953 1.547 2.264 3.881
PI54 C
How often did pain keep you from getting
into a standing position? 0.948 1.401 1.801 2.103 2.524
PI55 B
How often did pain prevent you from sitting
for more than one hour? 0.657 1.111 1.675 2.347 2.934
PI56 A How irritable did you feel because of pain? 0.005 0.884 1.558 2.168 3.035
*
For all items, the time frame was the past 7 days. The response sets were:
A = Not at all/A little bit/Somewhat/Quite a bit/Very much
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C = Never/Once a week or less/Once every few days/Once a day/Every few hours
b1, b2, b3, b4 = estimated item category difficulties
a = estimated item discrimination
ˆ
Item names are based on their location in the original candidate item pool; therefore, PI1, for example is the first Pain
Interference item.
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Figure 1. Distribution of PROMIS-Pain Interference T-Scores by Sample (T-Scores Have a
Mean of 50 and a Standard Deviation (SD) of 10)
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Figure 2. Information and Reliability Associated with Pain Impact Items Compared to
Distribution of Pain Impact T-Scores in the Combined Samples
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Table 3
Pearson-Product Moment Correlations (r) and Spearman's Rank Correlations (rho)
between PROMIS-Pain Interference Scores and Scores on Other Measures
Measure N r
Other PROMIS Measures:
 Physical Function 14,824 -0.55
 Fatigue 14,002 0.48
 Anxiety 11,911 0.35
 Depression 9,558 0.33
Other Pain Measures: rho
 BPI Interference Scale 780* 0.9
 SF-36 Bodily Pain Subscale 730* -0.84
 0-10 Numerical Rating of Pain Intensity 519** 0.48
*
BPI Interference Scale [14] and the SF-36 Bodily Pain Subscale [60] were only administered to participants in the full bank testing arm of the
study (N=845).
**
The correlation was computed for the chronic pain sample only because of high proportion of people with no pain in the general sample
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